Early real-world utilization of ADA-adaz (Hyrimoz) in the United States: A retrospective claims-based descriptive study. [PDF]
Chen A +6 more
europepmc +1 more source
Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions-a narrative review. [PDF]
Cao Y +6 more
europepmc +1 more source
Switching Between Reference Adalimumab and Biosimilars in Adult Patients With Inflammatory Bowel Disease: A Systematic Literature Review. [PDF]
Nabhan S +8 more
europepmc +1 more source
Fundamental changes in regulation to improve access to biosimilars. [PDF]
Kang HN, Knezevic I, Wadhwa M, Kim EK.
europepmc +1 more source
The Current Use and Future Perspectives of Biosimilars in Pediatric Healthcare: A Narrative Review. [PDF]
Ahmed Z +6 more
europepmc +1 more source
Economic evaluation of newly approved cetuximab biosimilars for first-line treatment of RAS/BRAF wild-type metastatic colorectal cancer in China. [PDF]
Feng R +6 more
europepmc +1 more source
Osteoporosis treatment with biosimilars in Malaysia and Thailand: a budget impact analysis. [PDF]
Siachalinga L +7 more
europepmc +1 more source
Advances in Biosimilars: A Systematic Review of Machine Learning Applications. [PDF]
Duarte V, Bas TG.
europepmc +1 more source

